Future of Medicinal Cannabis, page-3

The index is down because it was massively over-hyped and basically none of the companies have delivered on the marketing talk. Sure the legislation changes are slower than expected but that was always a risk and something that many have underestimated. Fact is you simply had too many start ups in too short a time all trying to flood a very small market.

Nothing new you just need to look at Canada, yes there are great success stories but for each of those there are 10+ failed start ups. Not even unique to medical cannabis, the same applies to tech start ups, junior explorers and general bio tech stocks.

The index is down but go do some fundamental analysis on those stocks and it doesn't take long to work out why they are where they are. The main contributing factor in all of them is they are well behind plan on delivering to market. Whether that be that they underestimated the complexity of getting licences, the time taken to build facilities to begin production or overestimated the ability or partnerships to deliver products to market or a combination of those.